RXi Pharmaceuticals Corporation

Company Profile Information

Company Description

RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology that address

More

$1 mil. - $5 mil.in Revenue

257 Simarano Drive Suite 101MarlboroughMassachusetts01752United States

view map

(508) 303-3400(508) 767-3862Fax

Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.

More Company Info

Stock Market

(NASDAQ: RXII)

SIC Codes

2834

NAICS Codes

325412

Recently updated profiles at this company
(19 contacts available)
Karen Bulock
Vice President, Research
Geert Cauwenbergh
President and Chief Executive Officer
James Cardia
Director of Business Development and Intellectual Property
Jennifer Ruel
Administrative Assistant
  • View Contact Info >>
  • Contact people at this company
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.